<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Neurothera Labs Inc. — News on 6ix</title>
    <link>https://6ix.com/company/neurothera-labs-inc</link>
    <description>Latest news and press releases for Neurothera Labs Inc. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 23 Apr 2026 22:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/neurothera-labs-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69eb9254ec513269ec705190.webp</url>
      <title>Neurothera Labs Inc.</title>
      <link>https://6ix.com/company/neurothera-labs-inc</link>
    </image>
    <item>
      <title>Neurothera Labs Engages bullVestor for Investor Relations Activities</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-engages-bullvestor-for-investor-relations-activities</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-engages-bullvestor-for-investor-relations-activities</guid>
      <pubDate>Thu, 23 Apr 2026 22:00:00 GMT</pubDate>
      <description>(TheNewswire)     April 23,   2026   &amp;#x2013;   TheNewswire -   Vancouver,   British   Columbia, ...</description>
    </item>
    <item>
      <title>NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-clearmind-medicine-collaboration-leads-to-patent-application-for-depression-therapy-1</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-clearmind-medicine-collaboration-leads-to-patent-application-for-depression-therapy-1</guid>
      <pubDate>Mon, 16 Mar 2026 11:30:00 GMT</pubDate>
      <description>(TheNewswire)  &amp;#xA0;    Vancouver, British Columbia   &amp;#x2013;   TheNewswire -   March 16, 2026 ...</description>
    </item>
    <item>
      <title>Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/clearmind-medicine-announces-hong-kong-patent-filing-for-depression-therapy-121</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/clearmind-medicine-announces-hong-kong-patent-filing-for-depression-therapy-121</guid>
      <pubDate>Fri, 13 Mar 2026 11:45:00 GMT</pubDate>
      <description>Innovative non-hallucinogenic approach combines MEAI with Palmitoylethanolamide to tackle major d...</description>
    </item>
    <item>
      <title>NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-announces-publication-of-international-patent-in-collaboration-with-clearmind-medicine-for-novel-therapy-targeting-weight-loss-and-fatty-liver-disease-1</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-announces-publication-of-international-patent-in-collaboration-with-clearmind-medicine-for-novel-therapy-targeting-weight-loss-and-fatty-liver-disease-1</guid>
      <pubDate>Wed, 11 Mar 2026 11:30:00 GMT</pubDate>
      <description>(TheNewswire)  &amp;#xA0; &amp;#xA0;    Vancouver, British Columbia &amp;#x2013; March 11, 2026 &amp;#x2013;   Th...</description>
    </item>
    <item>
      <title>Neurothera Labs Inc. Announces Definitive Agreement To Acquire Majority Stake In Cliniquantum Ltd.</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-inc-announces-definitive-agreement-to-acquire-majority-stake-in-cliniquantum-ltd</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-inc-announces-definitive-agreement-to-acquire-majority-stake-in-cliniquantum-ltd</guid>
      <pubDate>Tue, 10 Mar 2026 11:30:00 GMT</pubDate>
      <description>(TheNewswire)  &amp;#xA0;    Vancouver, British Columbia &amp;#x2013; March 10, 2026 &amp;#x2013;   TheNewswi...</description>
    </item>
    <item>
      <title>Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-granted-us-patent-for-cannabinoid-technology-to-overcome-antimicrobial-resistance-such-as-mrsa</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-granted-us-patent-for-cannabinoid-technology-to-overcome-antimicrobial-resistance-such-as-mrsa</guid>
      <pubDate>Mon, 02 Feb 2026 13:00:00 GMT</pubDate>
      <description>(TheNewswire)     Proprietary Cannabinoid-Enhanced Platform Targets Antibiotic Resistance Using A...</description>
    </item>
    <item>
      <title>Neurothera Labs Announces Results of AGM</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-announces-results-of-agm</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-announces-results-of-agm</guid>
      <pubDate>Thu, 08 Jan 2026 23:00:00 GMT</pubDate>
      <description>(TheNewswire)  &amp;#xA0;    January 8, 2026 &amp;#x2013;   TheNewswire -   Vancouver, British Columbia, ...</description>
    </item>
    <item>
      <title>Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-granted-patent-by-israeli-patent-office-for-its-proprietary-opioid-based-patent-family-to-enhance-pain-relief-and-reduce-side-effects</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-granted-patent-by-israeli-patent-office-for-its-proprietary-opioid-based-patent-family-to-enhance-pain-relief-and-reduce-side-effects</guid>
      <pubDate>Tue, 30 Dec 2025 13:00:00 GMT</pubDate>
      <description>(TheNewswire)      &amp;#xA0;      December 30, 2025 &amp;#x2013;   TheNewswire -   Vancouver, British Co...</description>
    </item>
    <item>
      <title>Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-signs-non-binding-term-sheet-to-acquire-majority-stake-in-a-quantum-algorithm-bio-data-analysis-company</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-signs-non-binding-term-sheet-to-acquire-majority-stake-in-a-quantum-algorithm-bio-data-analysis-company</guid>
      <pubDate>Tue, 02 Dec 2025 13:05:00 GMT</pubDate>
      <description>(TheNewswire)     December 2, 2025 &amp;#x2013;   TheNewswire -   Vancouver, British Columbia, Canada...</description>
    </item>
    <item>
      <title>SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/scisparc-neurothera-labs-announces-israeli-patent-application-in-collaboration-with-clearmind-medicine-for-novel-non-hallucinogenic-neuroplastogen-treatment-for-depression</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/scisparc-neurothera-labs-announces-israeli-patent-application-in-collaboration-with-clearmind-medicine-for-novel-non-hallucinogenic-neuroplastogen-treatment-for-depression</guid>
      <pubDate>Thu, 20 Nov 2025 11:42:00 GMT</pubDate>
      <description>TEL AVIV, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (&amp;#x201C;Company...</description>
    </item>
    <item>
      <title>Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-announces-israeli-patent-application-in-collaboration-with-clearmind-medicine-for-novel-non-hallucinogenic-neuroplastogen-treatment-for-depression-1</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/neurothera-labs-announces-israeli-patent-application-in-collaboration-with-clearmind-medicine-for-novel-non-hallucinogenic-neuroplastogen-treatment-for-depression-1</guid>
      <pubDate>Wed, 19 Nov 2025 13:30:00 GMT</pubDate>
      <description>(TheNewswire)     November 19, 2025 &amp;#x2013;   TheNewswire -   Vancouver, British Columbia, Canad...</description>
    </item>
    <item>
      <title>Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression</title>
      <link>https://6ix.com/company/neurothera-labs-inc/news/clearmind-medicine-files-israeli-patent-for-novel-non-hallucinogenic-neuroplastogen-treatment-for-depression-1</link>
      <guid isPermaLink="true">https://6ix.com/company/neurothera-labs-inc/news/clearmind-medicine-files-israeli-patent-for-novel-non-hallucinogenic-neuroplastogen-treatment-for-depression-1</guid>
      <pubDate>Mon, 17 Nov 2025 12:55:00 GMT</pubDate>
      <description>Vancouver, Canada, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE...</description>
    </item>
  </channel>
</rss>